All opinions contained within pieces presented on this page are published at the discretion of the author and/or publisher. The DETOUR System is an investigational device limited by United States law to investigational use. The DETOUR System is not available for sale.

Healio: DETOUR I: 18-month Results Encouraging For Percutaneous Bypass System

11/9/2018

VIVA Physicians: Groundbreaking Endovascular Clinical Trial Results Announced At VIVA 18

11/6/2018

Healio: DETOUR I- Percutaneous Bypass Procedure Successful at 12 Months

7/1/2018

Endovascular Today: Twelve-Month Data Presented for PQ Bypass' Detour System

6/28/2018

Mass Device: PQ Bypass Touts 1-year Detour Study Data

6/28/2018

PQ Bypass: PQ Bypass Reports Positive 12-Month Results for Entirely New Procedure to Treat Extremely Long SFA Lesions in Patients with PAD

6/28/2018

PQ Bypass: PQ Bypass Announces First Patient Treated in Landmark DETOUR II Trial Evaluating New Treatment Approach for Clogged Leg Arteries

2/22/2018

Endovascular Today: PQ Bypass Receives IDE to Initiate DETOUR II Pivotal Trial

12/13/2017

PQ Bypass: PQ Bypass Reports Positive Results for the Novel DETOUR System in Patients With Tough to Treat Long Blockages in the Femoropopliteal Artery

9/12/2017

Mass Device: PQ Bypass Touts Subset Analysis Data from DETOUR System Trial

9/12/2017

PQ Bypass: PQ Bypass to Unveil New Data From DETOUR I at VIVA 17

9/8/2017

Frost & Sullivan: PQ Bypass- Recipient of Frost & Sullivan's 2017 European Peripheral Artery Disease Interventions Technology Innovation Award

8/31/2017

Frost & Sullivan: PQ Bypass Earns Frost & Sullivan's European Technology Innovation Award for Its Proprietary DETOUR System for Percutaneous Bypass

8/31/2017

Cision: PQ Bypass Earns Frost & Sullivan's European Technology Innovation Award

8/31/2017

Cision: Sanarus Technologies Appoints Senior Medtech Executive Heather Simonsen to Board of Directors

4/24/2017

Vascular News: PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies

3/14/2017

Medical Design Technology: PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies

3/14/2017

Medical Device Network: PQ Bypass's DETOUR Percutaneous Technologies Secure CE mark

3/14/2017

FierceBiotech: PQ Bypass Gets CE Mark for Peripheral Artery Disease Tech

3/13/2017

Mass Device: PQ Bypass Wins CE Mark for Trio of PAD Tools

3/13/2017

Endovascular Today: CE Mark Granted for PQ Bypass' Detour Percutaneous Bypass Technologies

3/13/2017

PQ Bypass: PQ Bypass Announces CE Mark for DETOUR Percutaneous Bypass Technologies

3/13/2017

TCTMD: Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

2/10/2017

PQ Bypass: PQ Bypass Announces Positive Results From DETOUR I Study at LINC 2017

1/24/2017

PQ Bypass: PQ Bypass Announces Schedule of Presentations at LINC 2017

1/19/2017

Mass Device Today: Personnel Moves Sept. 15, 2016

9/15/2017

Endovascular Today: Early Findings Presented for PQ Bypass’ Endovascular Femoropopliteal Artery Bypass Procedure

9/14/2016